Patents by Inventor Sreekant Nadkarni

Sreekant Nadkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DUAL-RELEASE COMPOSITIONS OF A CYCLOOXYGENASE-2 INHIBITOR
    Publication number: 20070202170
    Abstract: Pharmaceutical compositions are provided comprising one or more orally deliverable dose units, each comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility, for example celecoxib, in an immediate-release fraction and a controlled-release, slow-release, programmed-release, timed-release, pulse-release, sustained-release or extended-release fraction. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
    Type: Application
    Filed: May 4, 2007
    Publication date: August 30, 2007
    Inventors: Subhash Desai, Sreekant Nadkarni, Randy Wald, Gary DeBrincat
  • Sustained-release formulation of a cyclooxygenase-2 inhibitor
    Publication number: 20040062803
    Abstract: There is provided an orally deliverable pharmaceutical composition comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility such as celecoxib and a release-extending polymer. The composition is useful in treatment of cyclooxygenase-2 mediated conditions and disorders by once-a-day administration.
    Type: Application
    Filed: February 11, 2003
    Publication date: April 1, 2004
    Inventors: David B. Hedden, Sreekant Nadkarni
  • Sustained-release formulation of a cyclooxygenase-2 inhibitor
    Publication number: 20030219488
    Abstract: There is provided an orally deliverable pharmaceutical composition comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility such as celecoxib and a release-extending polymer. The composition is useful in treatment of cyclooxygenase-2 mediated conditions and disorders by once-a-day administration.
    Type: Application
    Filed: February 11, 2003
    Publication date: November 27, 2003
    Inventors: David B. Hedden, Sreekant Nadkarni
  • Sustained-release formulation of a cyclooxygenase-2 inhibitor
    Publication number: 20030170303
    Abstract: There is provided an orally deliverable pharmaceutical composition comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility such as celecoxib and a release-extending polymer. The composition is useful in treatment of cyclooxygenase-2 mediated conditions and disorders by once-a-day administration.
    Type: Application
    Filed: January 28, 2003
    Publication date: September 11, 2003
    Inventors: David B. Hedden, Sreekant Nadkarni
  • Sustained-release formulation of a cyclooxygenase-2 inhibitor
    Publication number: 20020015735
    Abstract: There is provided an orally deliverable pharmaceutical composition comprising a selective cyclooxygenase-2 inhibitory drug of low water solubility such as celecoxib and a release-extending polymer. The composition is useful in treatment of cyclooxygenase-2 mediated conditions and disorders by once-a-day administration.
    Type: Application
    Filed: December 20, 2000
    Publication date: February 7, 2002
    Inventors: David B. Hedden, Sreekant Nadkarni
  • Valdecoxib compositions
    Publication number: 20020013357
    Abstract: Pharmaceutical compositions are provided comprising particulate valdecoxib in an amount of about 1 mg to about 100 mg and one or more pharmaceutically acceptable excipients. The compositions are useful in treatment or prophylaxis of cyclooxygenase-2 mediated conditions and disorders.
    Type: Application
    Filed: December 6, 2000
    Publication date: January 31, 2002
    Inventors: Sreekant Nadkarni, Mark J. Kontny